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Summary
Peroxisomal b-oxidation proceeds from enoyl-CoA
through D-3-hydroxyacyl-CoA to 3-ketoacyl-CoAby the
D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxy-acyl-
CoA dehydrogenase bifunctional protein (D-bifunctional
protein), and the oxidation of bile-acid precursors also
has been suggested as being catalyzed by the D-
bifunctional protein. Because of the important roles of
this protein, we reinvestigated two Japanese patients
previously diagnosed as having enoyl-CoA hydratase/L-
3-hydroxyacyl-CoA dehydrogenase bifunctional protein
(L-bifunctional protein) deficiency, in complementation
studies. We found that both the protein and the enzyme
activity of the D-bifunctional protein were hardly
detectable in these patients but that the active L-
bifunctional protein was present. The mRNA level in
patient 1 was very low, and, for patient 2, mRNA was
of a smaller size. Sequencing analysis of the cDNA
revealed a 52-bp deletion in patient 1 and a 237-bp
deletion in patient 2. This seems to be the first report
of D-bifunctional protein deficiency. Patients previously
diagnosed as cases of L-bifunctional protein deficiency
probably should be reexamined for a possible D-
bifunctional protein deficiency.
Introduction
The peroxisomal fatty-acid b-oxidation cycle was con-
sidered to be catalyzed by acyl-CoA oxidase, enoyl-CoA
hydratase/L-3-hydroxyacyl-CoA dehydrogenase bifunc-
tional protein (L-bifunctional protein), and peroxisomal
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3-ketoacyl-CoA thiolase (Hashimoto 1982). Increasing
numbers of cases with deficiencies of peroxisomal b-
oxidation enzymes, characterized by severe psychomotor
delay and an accumulation of very-long-chain fatty acids
(VLCFAs), have been reported (Schram et al. 1987; Poll-
The et al. 1988; Watkins et al. 1989, 1995; Wanders et
al. 1990, 1992; Suzuki et al. 1994). It seems that only
VLCFAs accumulate in patients with acyl-CoA oxidase
deficiency (Poll-The et al. 1988), whereas both VLCFAs
and bile-acid intermediates accumulate in patients with
bifunctional protein deficiency (Clayton et al. 1988;
Watkins et al. 1989).
Recently, we purified D-3-hydroxyacyl-CoA dehydra-
tase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional
protein (D-bifunctional protein), which converts enoyl-
CoAs to 3-ketoacyl-CoAs via D-3-hydroxyacyl-CoAs, in
peroxisomes (Jiang et al. 1996a, 1996b). In other stud-
ies, we suggested that the peroxisomal b-oxidation in
human skin fibroblasts proceeds from enoyl-CoA
through D-3-hydroxyacyl-CoA to 3-ketoacyl-CoA by D-
bifunctional protein but not by L-bifunctional protein,
since the content and the activity of L-bifunctional pro-
tein are very low in cultured human skin fibroblasts, as
compared with those of D-bifunctional protein (Jiang et
al. 1997a). Furthermore, oxidation of bile-acid precur-
sors and 2-methyl-branched fatty acids also has been
suggested as being catalyzed by D-bifunctional protein
but not by L-bifunctional protein (Jiang et al. 1997a).
Because of the important roles of D-bifunctional pro-
tein, we reinvestigated the two Japanese patients who
were diagnosed as having L-bifunctional protein defi-
ciency, by means of a complementation study using an
established cell line with L-bifunctional protein defi-
ciency (Suzuki et al. 1994). Measurement of the specific
activity of L-bifunctional protein was impossible at that
time, and D-bifunctional protein had not been identified
yet. We now have clarified the deficiency of the protein
and the enzyme activity of D-bifunctional protein, and
molecular analyses have revealed mutations in the
cDNA.
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Patients and Methods
Patients
Patient 1 was a female child of consanguineous Jap-
anese parents (second cousins). The mother was gravida
I, para I, and had not experienced a miscarriage. Hy-
potonia, mild craniofacial dysmorphism (scaphocephaly,
frontal bossing, micrognathia, and high-arched palate),
hepatic dysfunction, multifocal tonic-clonic convulsions,
and calcific stippling of the shoulder and knee jointswere
present in patient 1. She could smile and follow a person,
at 3 mo of age, then she regressed. She manifested ad-
renocortical insufficiency from 11 mo of age and died
of airway obstruction at 21 mo of age.
Patient 2 was a female child of nonconsanguineous
parents of Japanese origin. The mother was gravida I,
para I, and had not experienced a miscarriage. Profound
hypotonia, psychomotor delay, intractable convulsions,
craniofacial dysmorphism (large fontanelle, frontal boss-
ing, low nasal bridge, and upward slanting of palpebral
fissures), funnel chest, talipes equinovarus, calcific stip-
pling of the patella, and hepatomegaly were present in
patient 2 soon after obstetric delivery. She suffered a
subdural hematoma due to vitamin K deficiency, on the
49th postnatal day, and died of pneumonia at 12 mo of
age (Nakada et al. 1993).
Accumulation of VLCFAs and bile-acid intermediates,
such as 3a,7a,12a-trihydroxy-5b-cholestanic acid, and
decreased activity of lignoceric acid oxidation, in fibro-
blasts, were evident. The enzyme protein of peroxisomal
acyl-CoA oxidase, L-bifunctional protein, and 3-ketoa-
cyl-CoA thiolase were detected. Cell-fusion study re-
vealed that both patients 1 and 2 belonged to the same
complementation group as the cell line from a patient
previously diagnosed with L-bifunctional protein defi-
ciency with negative cross-reactive material (Suzuki et
al. 1994). Control specimens (fibroblasts and autopsied
liver tissues) were obtained, with permission, from pa-
tients with other disorders.
Enzyme Assay
Enoyl-CoA hydratase activity was assayed by a de-
crease in absorbance at 280 nm in the presence of 0.1
mM crotonyl-CoA or octenoyl-CoA, as described else-
where (Jiang et al. 1996a, 1996b). D-3-Hydroxyacyl-
CoA dehydratase activity was assayed with 0.1 mM D-
3-hydroxyoctanoyl-CoA. 3-Hydroxyacyl-CoA dehydro-
genase activity was assayed with 20 mMacetoacetyl-CoA
and 0.1 mM NAD, as described elsewhere (Kobayashi
et al. 1996). The enzyme activities were assayed at 30C,
and one enzyme unit was defined as the amount of en-
zyme converting 1 mmol substrate/min, under the assay
conditions. [1-14C]-Palmitate and [1-14C]-lignocerate ox-
idation activities were assayed as described elsewhere
(Suzuki et al. 1991).
Procedures for Protein Analysis
Preparation II of D-bifunctional protein and L-bifunc-
tional protein were purified from human liver (Jiang et
al. 1996a), and antibodies against these enzymes were
prepared. Antibodies against crotonase (Furuta et al.
1980), acyl-CoA oxidase (Osumi et al. 1980), and per-
oxisomal 3-ketoacyl-CoA thiolase (Miyazawa et al.
1980) were developed with rat enzymes. Protein con-
centration was determined by a modification (Markwell
et al. 1978) of a procedure described by Lowry et al.
(1951). SDS-PAGE and western blotting were performed
as described elsewhere (Laemmli 1970; Towbin et al.
1979). Color development was done by use of alkaline
phosphatase–conjugated goat anti–rabbit IgG antibody
(KPL Laboratories) and the nitro blue tetrazolium/5-
bromo-4-chloro-3-indolyl phosphate substrate kit
(Pierce).
Skin Fibroblasts and Preparation of Extract
Fibroblasts were cultured in Dulbecco’s modified Ea-
gle’s medium supplemented with 10% (v/v) FCS. The
cells were trypsinized, washed with PBS, and spun down.
The cell pellet was suspended in 50 mM potassium phos-
phate, pH 7.5, 0.5% Tween 20, 0.2 M NaCl, 2 mM
mercaptoethanol, and 1 mM EDTA. After standing on
ice for 30 min, the suspension was centrifuged at 10,000
g for 10 min, and the supernatant was preserved.
Immunofluorescence Examination of Fibroblasts
Cultured fibroblasts were fixed with 4% paraformal-
dehyde and 0.1 M potassium phosphate, pH 7.4, were
permeabilized with 0.1% Triton X-100 and PBS, and
were blocked with 4% FCS, 0.1% Triton X-100, and
PBS. The cells were treated with anti–D-bifunctional pro-
tein rabbit antibody and anti–human catalase guinea pig
antibody, kindly provided by Dr. S. Yokota of the
Yamanashi Medical College, and then were doubly
stained with FluoroLink Cy3-labeled goat anti–rabbit
IgG and FluoroLink Cy3-labeled goat anti–mouse IgG
(Amersham).
Pulse-Labeling Experiment
Fibroblasts were grown in 28-cm2 dishes, were prein-
cubated with methionine-depleted Eagle’s minimum es-
sential medium containing 5% dialyzed FCS, and then
were incubated with 18.5 MBq 35S-methionine, as de-
scribed elsewhere (Yamaguchi et al. 1988). After 3 h,
the cells were extracted with 50 mM potassium phos-
phate, pH 7.5, 0.2 M NaCl, 2 mM mercaptoethanol,
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Figure 1 Immunoblot analysis of D-bifunctional protein in fi-
broblasts. Lane 1, Enzyme (20 ng). Lanes 2–4, Controls; Lane 5, Pa-
tient 1; Lane 6, Patient 2 (15 mg protein).
0.5 mM EDTA, 0.5% (v/v) Tween 20, 1 mg BSA/ml, 10
mg protease inhibitors/ml, and 10 mM methionine. The
extract was treated with the anti–D-bifunctional protein,
and the immune complex was recovered with 50 ml of
20% fixed Staphylococcus aureus cells (w/v). The S. au-
reus cells were washed twice with PBS containing 0.1%
Tween 20 and once with saline containing 0.1% Tween
20 and 0.05% SDS and then were subjected to SDS-
PAGE and fluorography. Competition experiments were
performed by use of an excess amount of the purified
D-bifunctional protein, during immunoprecipitation.
Northern Blot Analysis
cDNA for human D-bifunctional protein had been iso-
lated previously (Jiang et al. 1997b). The region of the
cDNA ([37]–2350) of D-bifunctional protein was used
as a probe in northern blot analysis. This region was
completely matched to that of the human 17 b-hydroxy-
steroid dehydrogenase IV cDNA (Adamski et al. 1995).
Digoxigenin (DIG) RNA-labeling and DIG luminescent-
detection kits were from Boehringer Mannheim. Full-
length cDNA of human L-bifunctional protein (Fukuda
et al., in press) and b-actin gene fragments (Iijima et al.
1985) also were used as probes. Total RNAs were
isolated from skin fibroblasts by means of the acid guani-
dinium thiocyanate-phenol-chloroform extraction
method (Chomczynski and Sacchi 1987). The RNAs
were denatured, electrophoresed in a 1% agarose gel
containing formaldehyde, and transferred to a Hybond
N membrane (Amersham). Hybridization, preparation
of the DIG-labeled antisense RNAs, and detection were
performed in accordance with the manufacturer’s
protocols.
PCR Amplification and Sequencing
D-Bifunctional protein cDNA was synthesized from
fibroblast RNA by a reverse-transcriptase (RT) reaction.
The coding region of the cDNA ([20]–2230) was am-
plified by PCR, by use of an LA PCR Kit (Takara), with
the primer set 5′-TGTCGTTGCAGGCCTTATTC-3′ and
5′-TAATAGTGTAGTGTGCCCTTC-3′. The 25 cycles
of PCR reaction were performed by use of a DNA Ther-
mal Cycler 480 (Perkin Elmer Japan, Applied Biosys-
tems), under the following conditions: 96C for 30 s,
60C for 1 min, and 72C for 10 min. The PCR products
were separated, by electrophoresis, on a 1% (w/v) aga-
rose gel and were extracted from the gel by use of a
GENECLEAN II kit (BIO 101). Subcloning of PCR-am-
plified cDNA was performed by use of a pT7Blue T-
vector (Novagen). Sequencing was performed by the di-
deoxy-sequencing method (Sanger et al. 1977) by use of
a Dye Terminator Cycle Sequencing kit (Perkin Elmer
Japan, Applied Biosystems).
Results
Absence of D-Bifunctional Protein in the Patients
With immunoblot analysis of D-bifunctional protein,
enzyme-preparation II gave signal bands with masses of
77 kD, 68 kD, and 46 kD (fig. 1, lane 1). Native D-
bifunctional protein was suggested to be a homodimer
of a 77-kD polypeptide. Bands of 68 kD and 46 kD
were considered to be degradation products (Jiang et al.
1996a). The fibroblasts from three control subjects gave
only one band, with a mass of 77 kD (fig. 1, lanes 2, 3,
and 4). However, neither the 77-kD subunit nor its pro-
teolytically processed polypeptide was detected for either
patient (fig. 1, lanes 5 and 6).
A band for L-bifunctional protein was found in the
fibroblasts both of controls and of the patients (fig. 2).
This band previously had been confirmed to be the L-
bifunctional protein (Jiang et al. 1997a). The amount of
L-bifunctional protein was greatly reduced in fibroblasts
from patient 1 and was moderately reduced in those
from patient 2. Acyl-CoA oxidase and peroxisomal 3-
ketoacyl-CoA thiolase also were detected in fibroblasts
from the patients (data not shown).
D-Bifunctional protein also was defective in the pa-
tients’ liver tissue (fig. 3A), even when a large amount
of sample was loaded. The content of D-bifunctional
protein in the patients’ livers was estimated to be
of that found in the controls. L-Bifunctional pro-! 1/50
tein was clearly recognized in the patients (fig. 3B).
Immunocytochemical examination of the fibroblasts
revealed a typical punctate fluorescence pattern of per-
oxisomes, in the control fibroblasts, by use of the an-
tibody against D-bifunctional protein (fig. 4A), and this
1156 Am. J. Hum. Genet. 61:1153–1162, 1997
Figure 2 Immunoblot analysis of L-bifunctional protein in fi-
broblasts. Lane 1, Enzyme (1 ng). Lanes 2 and 3, Controls; Lane 4,
Patient 1; Lane 5, Patient 2 (30 mg protein). The arrowhead indicates
the position of the L-bifunctional protein.
Figure 3 Immunoblot analyses of liver tissue. A, Results for D-
bifunctional protein. Lane 1, Enzyme (10 ng). Lanes 2 and 3, Controls;
Lane 4, Patient 1; Lane 5, Patient 2 (5 mg protein). B, Results for L-
bifunctional protein. Lane 1, Enzyme (5 ng). Lanes 2 and 3, Controls;
Lane 4, Patient 1; Lane 5, Patient 2 (5 mg protein).
pattern was superimposable on that of catalase (fig. 4D).
However, only a small number of fluorescence dots were
observed in the patient samples (fig. 4B and C), which
is considered to be nonspecific fluorescence of the second
antibodies. The large punctate fluorescence pattern of
catalase was observed (fig. 4E and F), as described else-
where (Suzuki et al. 1994). Similar punctate patterns for
acyl-CoA oxidase and 3-ketoacyl-CoA thiolase were
seen (data not shown). The pattern for the L-bifunctional
protein was not evident, because content was low.
Defect of the Synthesis of the Enzyme Protein
A fluorographic band at a position of 77 kD was seen
in the pulse-labeling experiment for the control cells (fig.
5). This band disappeared in a competition experiment
with an excess amount of the purified enzyme. No band
was detected for the patients’ cells. Biosynthesis of acyl-
CoA oxidase, L-bifunctional protein, and 3-ketoacyl-
CoA thiolase was normal for both patients and controls
(Suzuki et al. 1994).
Absence of Catalytic Activities of D-Bifunctional
Protein
In control fibroblasts, treatment with anti–D-bifunc-
tional protein antibody resulted in a decrease in the de-
hydratase activities with medium-chain enoyl-CoA. The
titrated octenoyl-CoA hydratase activity was ∼160 mil-
liunits/mg (fig. 6A), a value similar to that for D-3-hy-
droxyoctanoyl-CoA dehydratase activity (data not
shown). On the other hand, no significant reduction in
octenoyl-CoA hydratase activity was observed after
treatment with the anti–D-bifunctional protein antibody,
for patients 1 and 2 (fig. 6B and C). Residual activities
after treatment with both anticrotonase and anti–D-bi-
functional protein may be attributed to the trifunctional
protein (Jiang et al. 1996a, 1996b).
D-3-Hydroxyoctanoyl-CoA dehydratase activity in a
control liver was 0.56  0.10 unit/mg protein of the
extract (n  5). The activity in samples from patients 1
and 2 was estimated to be !0.01 unit/mg protein.
Figure 7A shows results of the separation of D-bi-
functional and L-bifunctional proteins, by phosphocel-
lulose column chromatography, in a control liver. Two
octenoyl-CoA hydratase-activity peaks were observed;
the first peak exhibited D-3-hydroxy-octanoyl-CoA de-
hydratase activity, but the second peak showed no de-
hydratase activity. The substrate specificity of hydratase
activities in the first and second peaks was similar to
that of the purified D-bifunctional and L-bifunctional
proteins, indicating that the first peak is the D-bifunc-
tional protein and the second is the L-bifunctional pro-
tein. On the other hand, only the second peak was found
for patient 1 (fig. 7B). The L-3-hydroxyoctanoyl-CoA
dehydratase activity was identified in the second peak,
but the D-3-hydroxyoctanoyl-CoA dehydratase activity
was hardly detectable.
When the dehydrogenase activity was monitored by
acetoacetyl-CoA-dependent NADH oxidation, the first
peak, due to mitochondrial 3-hydroxyacyl-CoA dehy-
drogenase, and the second peak, due to the L-bifunc-
tional protein, were observed both in a control and in
patient 1 (fig. 7). The D-bifunctional protein fraction did
not exhibit dehydrogenase activity with acetoacetyl-CoA
but did so with 3-keto-octanoyl-CoA. In contrast, the
L-bifunctional protein fraction exhibited the activity
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Figure 4 Immunofluorescence examination of the D-bifunctional protein and the catalase. A, Results for control (D-bifunctional protein).
B, Results for patient 1 (D-bifunctional protein). C, Results for patient 2 (D-bifunctional protein). D, Results for control (catalase). E, Results
for patient 1 (catalase). F, Results for patient 2 (catalase). Bar  10 mm.
Table 1
Fatty-Acid Oxidation in Human Skin Fibroblasts
PALMITATE OXIDATION
(pmol/h/mg protein)
LIGNOCERATE OXIDATION
(pmol/h/mg protein)
SUBJECT (S) POCA Absent POCA Present POCA Absent POCA Present
Controls (n  5) 799  299 62  19 283  98 280  35
X-linked ALD patients (n  3)a 566  77 66  12 77  10 63b
Patient 1 785 14 24 15
Patient 2 763 32 25 15
Zellweger syndrome patients (n  5) 683  206 12  9 19  14 7  11
a ALD  adrenoleukodystrophy.
b n  1.
with both 3-keto-octanoyl-CoA and acetoacetyl-CoA.
These substrate specificities were similar to those of the
purified enzyme preparations. The ratios of hydratase
and dehydrogenase activities in the first and second
peaks also were similar to those of the purified D-bi-
functional and L-bifunctional proteins.
Oxidation of Palmitate and Lignocerate in Fibroblasts
Table 1 summarizes fatty-acid–oxidation activities in
the presence or the absence of sodium 2-(5-[4-chloro-
phenyl]pentyl)oxirane-2-carboxylate (POCA), a potent
inhibitor of carnitine palmitoyltransferase I (Suzuki et
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Figure 5 Results of pulse labeling of the D-bifunctional protein
in fibroblasts. Lane P, Pulse labeling for 3 h. Lane C, Competition
experiment using an excess amount of the purified enzyme. Arrow-
heads indicate the position of the 77-kD polypeptide of the D-bifunc-
tional protein.
Figure 6 Enoyl-CoA hydratase activities in fibroblasts. The activities were measured before and after immunoprecipitation. A, Results
for control. B, Results for patient 1. C, Results for patient 2.
al. 1991). Palmitate oxidation for patients 1 and 2 was
normal in the absence of POCA, thereby indicating the
normal mitochondrial b-oxidation of palmitate. In the
presence of POCA, palmitate oxidation for the patients
was lower, as has been observed for Zellweger syndrome,
a defect of functional peroxisomes. Lignocerate oxida-
tion remained unvaried with the addition of POCA, sug-
gesting that this activity reflects peroxisomal b-oxida-
tion. These activities in the patients also were reduced
markedly. We propose that D-bifunctional protein plays
a key role in the oxidation of long-chain fatty acids and
of VLCFAs, in human fibroblasts.
Northern Blot Analysis
The D-bifunctional protein mRNA from control fi-
broblasts was ∼2.7 kb. mRNA was not detected for pa-
tient 1 but was detected for patient 2. The content and
size of the L-bifunctional protein and the b-actinmRNAs
in the patients’ fibroblasts were similar to those in the
control fibroblasts (fig. 8).
Mutation Analysis
The coding region of D-bifunctional protein cDNA
was amplified by RT-PCR, to search for mutations (fig.
9). Although D-bifunctional protein mRNA was not de-
tected for patient 1, a small amount of cDNA was am-
plified. Two types of PCR products were identified for
patient 1. One allele had a 52-bp deletion encompassing
bases at nucleotide positions 1210–1261, which led to
a 17-amino-acid deletion at 404V–420A and which in-
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Figure 7 Phosphocellulose column chromatography of liver ex-
tracts. A, Results for control. B, Results for Patient 1. The liver (0.25
g) was extracted with the same extraction buffer used for the fibro-
blasts. After the extract was desalted by passage through a column of
Sephadex G-25 with 25 mM potassium phosphate, pH 7.5, 0.5%
Tween 20, 2 mM mercaptoethanol, 1 mM EDTA, and 10% (v/v)
ethylene glycol, the sample was applied onto a phosphocellulose col-
umn (2 ml, equilibrated with the desalting buffer). Elution was per-
formed after washing with 2ml of 50mMpotassium-phosphatebuffer,
by use of a linear-gradient concentration of potassium phosphate, pH
7.5, within a range of 50–200mM and containing the same ingredients
as the desalting buffer, in a total volume of 25 ml.
Figure 8 Results of northern blot analyses of mRNAs from
fibroblasts. Four milligrams of total RNA were used. The exposure
period to x-ray film was 7 min, 15 min, and 5 s, for detection of
mRNAs of D-bifunctional protein, L-bifunctional protein, and b-actin,
respectively. Lanes 1 and 2, Controls. Lane 3, Patient 1. Lane 4,
Patient 2.
troduced a premature termination codon at amino acid
position 423. An A1269rG substitution, with no amino
acid change, also was identified in both types of PCR
products. When PCR amplification was performed by
use of a set of the sense (976–996) and antisense
(1377–1357) primers, a 402-bp fragment was amplified
in the controls, whereas a 52-bp deleted fragment was
a major product for patient 1 (fig. 9B).
The PCR-amplified cDNA of patient 2 was smaller in
size than that of the controls, with a 237-bp deletion
encompassing bases at nucleotide positions 973–1209,
an event that led to an in-frame 79-amino-acid deletion
beginning at amino acid position 325 (fig. 9A). PCR
using a set of the sense (934–964) and the antisense
(1239–1219) primers produced a 306-bp fragment in
the controls, whereas only a 69-bp fragment was de-
tected for patient 2 (fig. 9C).
Discussion
The two patients investigated in this study were di-
agnosed previously as cases of L-bifunctional protein de-
ficiency, by means of a complementation study (Suzuki
et al. 1994). In the present study, examination of fibro-
blasts and of the autopsied livers from these patients
revealed that both the activity and the immunoreactive
material of D-bifunctional protein were absent. Muta-
tion analyses of the cDNA revealed the presence of a
short deletion in each patient, which produced a frame-
shift and a premature termination in patient 1 and an
in-frame 79-amino-acid deletion in patient 2. Mutation
analyses of family members could not be performed,
since permissions for skin biopsies were not obtained.
It is possible that other mutations, yet to be identified,
may have resulted in the absence of mRNA production
from the second allele, in both patients. The structure
of genomic DNA for human D-bifunctional protein and
mutations at the genomic level remain to be elucidated.
Since ∼46 kD of the C-terminal of the D-bifunctional
protein showed only dehydratase activity (Jiang et al.
1997b), deleted portions seem to belong to the dehy-
dratase domain. Results of northern blot analysis and
of PCR amplification of the cDNA indicate that the
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Figure 9 Results of PCR amplification of D-bifunctional protein
cDNA, and mutations in the patients. The entire coding region of the
D-bifunctional protein cDNA is indicated by the unblackened bar.
Lines A–C indicate the sections of PCR amplification, and the numbers
are the nucleotide positions of the cDNA corresponding to the 5′ ends
of the primers. The lane labeled “marker” indicates the size marker.
All lanes contain StyI-digested l-DNA as a size marker. The shaded
(1210–1261) and blackened (973–1209) areas of the bar indicate de-
letions in patients 1 and 2, respectively.
mRNA of patient 1 would be unstable or poorly tran-
scribed. On the other hand, the amount of mRNA in
patient 2 was almost normal, suggesting that the trun-
cated D-bifunctional protein with the in-frame 79-
amino-acid deletion would be degraded so rapidly that
it would not be detected in pulse-labeling experiments.
The content and the two activities of L-bifunctional pro-
tein were within a normal range, in liver tissues from
these patients, although the amount of L-bifunctional
protein in fibroblasts was reduced. Therefore, the actual
disease was D-bifunctional protein deficiency, not L-bi-
functional protein deficiency.
Several acyl-CoA compounds other than VLCFAs and
long-chain fatty acids are known to be oxidized pre-
dominantly in peroxisomes (Singh et al. 1990; Reddy
and Mannaerts 1994; Kunau et al. 1995). In a previous
study, we found distinct differences between functions
of the D-bifunctional and the L-bifunctional proteins
(Jiang et al. 1997a): D-bifunctional protein reacted with
2-methylhexadecenoyl-CoA, a branched fatty acid, and
with 3a,7a,12a-trihydroxy-5b-cholest-24-enoyl-CoA,
an intermediate metabolite of bile-acid synthesis. The
deficiency of peroxisomal acyl-CoA oxidase resulted in
accumulation of VLCFAs but not of pristanic acid
(2,6,10,14-tetramethylpentadecanoic acid) (ten Brink et
al. 1991a), whereas the pristanic acid concentration was
greatly elevated in patients with L-bifunctional protein
deficiency, as has been reported elsewhere (ten Brink et
al. 1991b; Van Veldhoven et al. 1993). Another char-
acteristic feature of peroxisomal b-oxidation is the bile-
acid formation from di- and trihydroxy-5b-cholestanic
acid to chenodeoxycholic acid and cholic acid, respec-
tively. Accumulation of bile-acid intermediates with an
uncleaved side chain, such as 3a,7a,12a-trihydroxy-5b-
cholestanic acid, occurs in peroxisome-biogenesis dis-
orders and in cases of L-bifunctional protein deficiency
(Watkins et al. 1989; Pedersen 1993; Natowicz et al.
1996).
In our previous study, the significance of D-bifunc-
tional protein in the metabolism of VLCFAs and of bile
acids, in peroxisomes, was clarified (Jiang et al. 1997a).
Both D-bifunctional and L-bifunctional protein were
highly expressed in hepatocytes. On the other hand, ex-
pression of L-bifunctional protein in fibroblasts was very
low, and D-bifunctional protein was considered to play
a major role in fibroblasts. Furthermore, b-oxidation of
branched-chain fatty acids and of bile-acid intermediates
was catalyzed exclusively by D-bifunctional protein, not
by L-bifunctional protein. Defects in the D-bifunctional
protein could explain not only the accumulation of
VLCFAs but also the accumulation of bile-acid inter-
mediates and of pristanic acid. We propose that patients
previously diagnosed as cases of L-bifunctional protein
deficiency probably should be reexamined.
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